Yes but we have found out that their so called discussions normally lead to nothing.
How can they say they are back on track to deliver per milestones when these milestones are already over due by months if not by years.
Artimist - MAA due April this year now not due until June next year.
Zolpimist - Lodging of MAA - 18 months late
ZolpiMist master license deal in Europe ✓ No
Further partnering deals with SUDA’s other candidates ✓ No
Monetisation of ArTiMist ✓ No
Expansion of Pfizer collaboration ✓
Early sales success for TEVA with ZolpiMist ✓ No
Expansion of TEVA markets ✓ No
Approval of ZolpiMIst in Australia and Europe No
So ABLM - is this what they are going to deliver
SUD Price at posting:
0.5¢ Sentiment: None Disclosure: Held
